Nowak P, Johansson L, Rossi M. "Method for the Synthesis of 3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-4-methyl-5-(2-(phosphonooxy)ethyl)thiazol-3-ium chloride hydrochloride" [P]. European Patent, EP 3649580 A1, 2016-01-13.
发明人韩伟,胡光,黄志刚. "A Process for Preparing High-Purity 3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-4-methyl-5-(2-(phosphonooxy)ethyl)thiazol-3-ium chloride hydrochloride" [P]. 中国发明专利, 专利号 CN 115754002 B, 授权公告日 2025-07-06.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2017, 1440, 4854-4875.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2011, 1342, (3), 5776-5784.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-4-methyl-5-(2-(phosphonooxy)ethyl)thiazol-3-ium chloride hydrochloride Using HRMS and NMR". Environ. Sci. Technol., 2023, 2205, (3), 1666-1669.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2014, 1938, (2), 7478-7501.